Guangzhou Novaken Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GUANGZHOU NOVAKEN, and what generic and branded alternatives to GUANGZHOU NOVAKEN drugs are available?
GUANGZHOU NOVAKEN has two approved drugs.
Summary for Guangzhou Novaken
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Guangzhou Novaken
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangzhou Novaken | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 213859-002 | Nov 18, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Guangzhou Novaken | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 214395-001 | Jan 28, 2021 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Guangzhou Novaken | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 214395-002 | Jan 28, 2021 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Guangzhou Novaken | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 213859-001 | Nov 18, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
